Discover your next big idea for life sciences at PACK EXPO Las Vegas
Experience a breakthrough in life sciences packaging—explore solutions from 2,300 suppliers spanning all industries, all in one place this September

Quick Hits: FDA Could Approve MDMA as Early as Next Year

Once known as a party drug, MDMA just received “expanded access” approval from the FDA for the treatment of PTSD.

A recent New York Post article discussed a new regulatory advancement for MDMA. The drug, commonly known as ecstasy or molly, is a psychoactive drug primarily known for recreational use. However, years of research and clinical trials have shown the drug can be an effective treatment for post-traumatic stress disorder (PTSD). The Multidisciplinary Association for Psychedelic Studies (MAPS) announced they have received “expanded access” approval from the FDA to continue research that could likely lead to the legalization of MDMA for medical purposes.

Medical Device Innovations Report
Cutting-edge packaging technologies are transforming the medical device sector in PMMI’s “Innovation in Medical Device” report, featuring advanced materials, smart solutions, and evolving regulations. Editors share insights from nearly 300 PACK EXPO booth visits—each product deemed new and truly innovative—alongside video demonstrations of the equipment and materials on display.
Learn More
Medical Device Innovations Report
Pharmaceutical Innovations Report
Discover the latest breakthrough packaging technologies shaping the pharmaceutical sector. This report dives into cutting-edge innovations, from smart containers that enhance patient safety to eco-friendly materials poised to transform the industry’s sustainability practices. All from PACK EXPO. Learn how forward-thinking strategies are driving efficiency and redefining what’s possible in pharma packaging.
Learn More
Pharmaceutical Innovations Report